Zobrazeno 1 - 10
of 1 717
pro vyhledávání: '"V. Shu"'
Autor:
Woźniak, Piotr1 (AUTHOR) piotr.wozniak@zut.edu.pl, Gryta, Marek1 (AUTHOR) marek.gryta@zut.edu.pl
Publikováno v:
Materials (1996-1944). Nov2024, Vol. 17 Issue 21, p5382. 16p.
Autor:
Molavi-Arabshahi, Mahboubeh1 (AUTHOR) molavi@iust.ac.ir, Rashidinia, Jalil1 (AUTHOR), Yousefi, Mahnaz1 (AUTHOR)
Publikováno v:
Scientific Reports. 10/27/2024, Vol. 14 Issue 1, p1-14. 14p.
Autor:
Lebiocka, Magdalena1 (AUTHOR) a.montusiewicz@pollub.pl, Montusiewicz, Agnieszka1 (AUTHOR) a.szaja@pollub.pl, Grządka, Elżbieta2 (AUTHOR) elzbieta.grzadka@mail.umcs.pl, Pasieczna-Patkowska, Sylwia2 (AUTHOR) sylwia.pasieczna-patkowska@mail.umcs.pl, Montusiewicz, Jerzy3 (AUTHOR) j.montusiewicz@pollub.pl, Szaja, Aleksandra1 (AUTHOR)
Publikováno v:
Molecules. Oct2024, Vol. 29 Issue 20, p4791. 15p.
Autor:
Perveen, Rabia1 (AUTHOR), Latif, Fiza2 (AUTHOR), Abbas, Minahil1 (AUTHOR), Ayub, Khurshid3 (AUTHOR), Sarfaraz, Sehrish3 (AUTHOR), Saeed, Muhammad4 (AUTHOR), Rana, Sobia5 (AUTHOR) molecularbiologist1@gmail.com, Al-Rashida, Mariya6 (AUTHOR), Nawaz, Muhammad Asif2 (AUTHOR) masif@uosahiwal.edu.pk, Hameed, Abdul1 (AUTHOR) drabdulhameed@uosahiwal.edu.pk
Publikováno v:
Scientific Reports. 10/10/2024, Vol. 14 Issue 1, p1-16. 16p.
Publikováno v:
Neurology. 48:182-188
This is the first randomized, double-blind, parallel-group, multicenter trial that evaluated the efficacy of divalproex sodium monotherapy by comparing seizure frequency in 143 patients with poorly controlled partial epilepsy randomly assigned to hig
Publikováno v:
Neurology. 46:49-53
Article abstract-We studied the efficacy of divalproex sodium in patients with complex partial seizures taking concomitant carbamazepine or phenytoin as monotherapy. Patients were selected because of inadequate seizure control by current therapy. The
Autor:
Alan Richens, James I. Morrow, Lennart Gram, Marianne Mikkelsen, Helle Mengel, M.W. Pierce, V. Shu, Mogens Dam, John S. Duncan, J.F. McKelvy, David Chadwick
Publikováno v:
Epilepsy Research. 21:37-42
Tiagabine is a new antiepileptic drug which acts by a novel mechanism, inhibiting the reuptake of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) into neurones and glia. A double-blind, placebo-controlled, crossover trial was undertake
Autor:
Delihowski, Jurij1 (AUTHOR) ydeli@agh.edu.pl, Izak, Piotr1 (AUTHOR), Wojcik, Łukasz1 (AUTHOR), Stempkowska, Agata2 (AUTHOR) stemp@agh.edu.pl, Jarosz, Marcin3 (AUTHOR)
Publikováno v:
Scientific Reports. 9/14/2024, Vol. 14 Issue 1, p1-16. 16p.
Autor:
Aguilar-Planet, Teresa1 (AUTHOR) maguilar8@us.es, Peralta, Estela1 (AUTHOR) mperalta1@us.es
Publikováno v:
Biomimetics (2313-7673). Sep2024, Vol. 9 Issue 9, p523. 30p.
Autor:
Keskin, Tugba1,2 (AUTHOR) tugba_keskin22@erdogan.edu.tr, Yilmaz, Erol1,3 (AUTHOR) erol.yilmaz@erdogan.edu.tr, Kasap, Tugrul1,2 (AUTHOR) muhammet.sari@erdogan.edu.tr, Sari, Muhammet1,2,3 (AUTHOR), Cao, Shuai4 (AUTHOR) erol.yilmaz@erdogan.edu.tr
Publikováno v:
Minerals (2075-163X). Sep2024, Vol. 14 Issue 9, p943. 31p.